Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02075918 · ClinicalTrials.gov registry record
Integrated Approaches for Identifying Molecular Targets in Alcoholic Hepatitis
A clinical trial, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 376
- Enrollment target
NCT02075918 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 376 participants.
The verdict
NCT02075918 has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 376 participants
- Enrollment target
Study Summary
Purpose: To improve the diagnosis and assessment of severity of acute alcoholic hepatitis Participants: Patients admitted to one of ten centers with acute alcoholic hepatitis Procedures (methods): Consecutive patients admitted with acute alcoholic hepatitis will be enrolled in an NIH U01 study of acute alcoholic hepatitis where liver tissue, blood and stool will be collected to discover and validate factors associated with diagnosis, severity of disease and survival.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 376 participants |
| Start Date | 2014-05 |
| Est. Completion | 2019-05-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02075918
The ClinicalTrials.gov registry entry for NCT02075918 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 376 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02075918 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02075918 about?
NCT02075918 is a clinical study titled "Integrated Approaches for Identifying Molecular Targets in Alcoholic Hepatitis". Purpose: To improve the diagnosis and assessment of severity of acute alcoholic hepatitis Participants: Patients admitted to one of ten centers with acute alcoholic hepatitis Procedures (methods): Consecutive patients admitted with acute alcoholic hepatitis will be enrolled in an NIH U01 study of ac...
What is the current status of trial NCT02075918?
This trial is currently completed. The enrollment target is 376 participants. The study started on 2014-05. Estimated completion is 2019-05-31.
Who is sponsoring clinical trial NCT02075918?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.